Skip to main content
Clinical Trials/TCTR20210218006
TCTR20210218006
Unknown
Phase 2

A comparison of allogenic blood transfusion between acute normovolemic hemodilution and standard care in patient undergoing cardiac surgery: A prospective randomized controlled study

Maharaj Nakorn Chiang Mai Hospital0 sites330 target enrollmentFebruary 18, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
umber of patients receiving transfusion of RBC during hospital stay between acute normovolemic hemodilution and standard care in cardiac surgery patients
Sponsor
Maharaj Nakorn Chiang Mai Hospital
Enrollment
330
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2021
End Date
February 18, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged \> 18 years old
  • Signed informed consent
  • Any cardiac surgical intervention on CPB
  • Elective surgery

Exclusion Criteria

  • 1\. Medical decision
  • 2\. Unstable coronary artery disease
  • : Recent MI (\<6wks)
  • : Unstable angina
  • : severe (\>70%) LM coronary artery stenosis
  • 3\. Critical preoperative : Hb \< 11 g/dL
  • : VF, aborted sudden cardiac death, preoperative cardiac massage
  • : Preoperative ventilation
  • : Hemodynamic instability
  • : Preoperative inotrope

Outcomes

Primary Outcomes

Not specified

Similar Trials